Spot Trading’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-15,452
Closed -$139K 3572
2016
Q3
$139K Buy
15,452
+4,600
+42% +$32.7K ﹤0.01% 2290
2016
Q2
$58K Sell
10,852
-7,626
-41% -$39.1K ﹤0.01% 2722
2016
Q1
$85K Sell
18,478
-159,576
-90% -$641K ﹤0.01% 2636
2015
Q4
$926K Buy
178,054
+148,346
+499% +$861K 0.01% 1510
2015
Q3
$180K Sell
29,708
-20,379
-41% -$250K ﹤0.01% 2760
2015
Q2
$791K Sell
50,087
-95,826
-66% -$1.16M 0.01% 1794
2015
Q1
$1.59M Buy
145,913
+24,302
+20% +$248K 0.02% 1269
2014
Q4
$1.28M Sell
121,611
-34,867
-22% -$341K 0.01% 1722
2014
Q3
$1.5M Sell
156,478
-44,742
-22% -$457K 0.01% 1761
2014
Q2
$2.32M Buy
+201,220
New +$1.83M 0.01% 1527

Spot Trading's RPTP Position: Q4 2016 in Review

Spot Trading sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 15,452 shares — an estimated $139K sold.

Spot Trading first reported a position in RPTP in Q2 2014 and held it in 10 quarters. The position peaked at $2.32M in Q2 2014. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Spot Trading reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 15,452 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $139K.
  • Spot Trading first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2014 and held it in 10 quarters.
  • Spot Trading's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.32M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.